Related Experiment Video
Updated: Dec 15, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Healthcare associated diarrhea, not Clostridioides difficile
Nicholas A Turner1, Jennifer L Saullo1, Christopher R Polage2,3
1Department of Medicine, Division of Infectious Diseases.
Healthcare-associated diarrhea (HCAD) is usually noninfectious, often caused by medications or medical conditions. Clinical assessment and targeted testing for Clostridioides difficile are key, with multiplex panels potentially useful for immunocompromised patients.
Area of Science:
- Infectious Diseases
- Gastroenterology
- Clinical Medicine
Background:
- Healthcare-associated diarrhea (HCAD) presents a diagnostic challenge.
- Understanding the epidemiology and causes of HCAD is crucial for effective management.
Purpose of the Study:
- To review the epidemiology, causes, diagnostic evaluation, and management of HCAD.
- To highlight current epidemiology and recent advancements in diagnostic approaches for HCAD.
Main Methods:
- Literature review focusing on epidemiology, diagnostics, and management of HCAD.
- Analysis of recent studies on enteropathogen detection and clinical assessment.
Main Results:
- HCAD is primarily a noninfectious condition, frequently linked to medications or underlying medical issues.
- Clostridioides difficile infection and viral causes are noted, but other infections are uncommon.
- Multiplex polymerase chain reaction (PCR) gastrointestinal panels offer broad pathogen detection but require further assessment for HCAD utility.
Conclusions:
- Clinical evaluation is fundamental for HCAD diagnosis.
- Targeted Clostridioides difficile testing is adequate for most HCAD cases.
- Medication-induced diarrhea is common and often overlooked; multiplex panels may benefit immunocompromised individuals, pending further research.
More Related Videos
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
11:13Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
Published on: September 14, 2013
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...